James E. Hulse Iii

MD | Pediatric Cardiology | Male

James E. Hulse Iii, MD is a Overland Park, Kansas based Pediatric doctor with medical specialization in Pediatric Cardiology. Current practice location of James E. Hulse Iii is 10500 Quivira Rd, Overland Park, Kansas - 66215-2306. He can be contacted on phone at 913-541-5000. James E. Hulse Iii is a sole proprietor of his business.
NPI number (Unique professional ID) for James E. Hulse Iii is 1407813298 which was assigned by NPPES on 27 Apr, 2006 and it was last updated on 11 Jun, 2014. James E. Hulse Iii license number is 115046 for Pediatrics Pediatric Cardiology (2080P0202X) in Missouri.
James E. Hulse Iii provides comprehensive care to patients with cardiovascular problems. This specialist is skilled in selecting, performing and evaluating the structural and functional assessment of the heart and blood vessels, and the clinical evaluation of cardiovascular disease.
Complete Profile:
James E. Hulse Iii basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Cardiology
Provider Name :James E. Hulse Iii
Credential :MD
Gender :Male
Business Address:
James E. Hulse Iii address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :10500 Quivira Rd
Overland Park, KS, 66215-2306
United States
Phone Number :913-541-5000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1407813298
NPI Entity Type : Individual
First Enrolment Date : 27 Apr, 2006
Last Updated On : 11 Jun, 2014
Medicare Participation:
James E. Hulse Iii participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :6507814902
Medicare Enrollment ID :I20181025000573
Primary Specialty :Pediatric Medicine
Medical School :Medical College Of Georgia School Of Medicine
Graduation Year :1985
Accepts Medicare?Yes. James E. Hulse Iii accepts medicare insurance.
Group Practice Association:
James E. Hulse Iii is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which James E. Hulse Iii is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Seattle Children's Hospital9032021050614800 Sand Point Way Ne
Seattle, WA - 981053901
Ph: 2069872000
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James E. Hulse Iii are as mentioned. Primary taxonomy code for James E. Hulse Iii, MD is 2080P0202X (Pediatrics Pediatric Cardiology).
Taxonomy Code SpecialityPrimaryLicense No.State
2080P0202XPediatrics Pediatric CardiologyYes115046MO
Legacy Identifiers:
Other legacy medical identifiers of James E. Hulse Iii such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
209991306MEDICAIDMO
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :10500 Quivira Rd
Overland Park, KS, 66215-2306
United States
Phone Number :913-541-5000
Business Location:
Patients can refer following map for directions to James E. Hulse Iii practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.